Mašek Jan, Andersson Emma R
Karolinska Institutet, Huddinge 14183, Sweden.
Karolinska Institutet, Huddinge 14183, Sweden
Development. 2017 May 15;144(10):1743-1763. doi: 10.1242/dev.148007.
Notch signaling regulates a vast array of crucial developmental processes. It is therefore not surprising that mutations in genes encoding Notch receptors or ligands lead to a variety of congenital disorders in humans. For example, loss of function of Notch results in Adams-Oliver syndrome, Alagille syndrome, spondylocostal dysostosis and congenital heart disorders, while Notch gain of function results in Hajdu-Cheney syndrome, serpentine fibula polycystic kidney syndrome, infantile myofibromatosis and lateral meningocele syndrome. Furthermore, structure-abrogating mutations in result in CADASIL. Here, we discuss these human congenital disorders in the context of known roles for Notch signaling during development. Drawing on recent analyses by the exome aggregation consortium (EXAC) and on recent studies of Notch signaling in model organisms, we further highlight additional Notch receptors or ligands that are likely to be involved in human genetic diseases.
Notch信号通路调控着大量关键的发育过程。因此,编码Notch受体或配体的基因突变导致人类多种先天性疾病也就不足为奇了。例如,Notch功能丧失会导致亚当斯 - 奥利弗综合征、阿拉吉尔综合征、脊椎肋骨发育不良和先天性心脏病,而Notch功能获得则会导致哈伊杜 - 切尼综合征、蛇形腓骨多囊肾综合征、婴儿肌纤维瘤病和外侧脑脊膜膨出综合征。此外,相关基因的结构破坏突变会导致伴有皮质下梗死和白质脑病的常染色体显性遗传性脑动脉病(CADASIL)。在此,我们将在Notch信号通路在发育过程中的已知作用背景下讨论这些人类先天性疾病。借助外显子组聚合联盟(EXAC)的最新分析以及对模式生物中Notch信号通路的最新研究,我们进一步强调了可能与人类遗传疾病相关的其他Notch受体或配体。